These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19777478)

  • 21. Whither agbiotechnology?
    Val Giddings L
    Nat Biotechnol; 2006 Mar; 24(3):274-6. PubMed ID: 16525385
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic biology through the prism of scenarios.
    Rutz B
    Biotechnol J; 2007 Sep; 2(9):1072-5. PubMed ID: 17703494
    [No Abstract]   [Full Text] [Related]  

  • 23. Systems biology is taking off.
    Ehrenberg M; Elf J; Aurell E; Sandberg R; Tegnér J
    Genome Res; 2003 Nov; 13(11):2377-80. PubMed ID: 14597651
    [No Abstract]   [Full Text] [Related]  

  • 24. The promise and perils of synthetic biology.
    Tucker JB; Zilinskas RA
    New Atlantis; 2006; 12():25-45. PubMed ID: 16832953
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biotechnology for medicine].
    Azarkin NM
    Med Sestra; 1988 Feb; 47(2):40-2. PubMed ID: 3163406
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical technology of the future.
    Christiano MR
    Group Pract J; 1986; 35(6):21-6. PubMed ID: 10289720
    [No Abstract]   [Full Text] [Related]  

  • 27. Present status of genetic engineering and biotechnology in South Korea.
    Cho MJ
    Crit Rev Biotechnol; 1990; 10(1):47-67. PubMed ID: 2186870
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene targeting from laboratory to livestock: current status and emerging concepts.
    Laible G; Alonso-González L
    Biotechnol J; 2009 Sep; 4(9):1278-92. PubMed ID: 19606430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical technologies for bioinformatics.
    Brusic V; Ranganathan S
    Brief Bioinform; 2008 Jul; 9(4):261-2. PubMed ID: 18499720
    [No Abstract]   [Full Text] [Related]  

  • 30. A view from the dark side.
    Searls DB
    PLoS Comput Biol; 2007 Jun; 3(6):e105. PubMed ID: 17604444
    [No Abstract]   [Full Text] [Related]  

  • 31. Particularities of clinical investigation with biotechnology products.
    Alsar MJ
    Methods Find Exp Clin Pharmacol; 1999; 21 Suppl B():11-3. PubMed ID: 10599038
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biochemistry as a background of modern biotechnology].
    Twardowski T
    Postepy Biochem; 2006; 52(1):7-9. PubMed ID: 16869296
    [No Abstract]   [Full Text] [Related]  

  • 33. From the decline and fall of protein chemistry to proteomics.
    Chakravarti DN
    Biotechniques; 2002 Mar; Suppl():2-3. PubMed ID: 11906003
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthetic biology.
    Tavassoli A
    Org Biomol Chem; 2010 Jan; 8(1):24-8. PubMed ID: 20024125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in biotechnology and bioinformatics.
    Nawani Neelu ; Pandey Ashok ; Khanal Samir ; Binod Parmeswaran
    Indian J Exp Biol; 2014 Nov; 52(11):1019-20. PubMed ID: 25434096
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthetic genomes: The next step for the synthetic genome.
    Baker M
    Nature; 2011 May; 473(7347):403, 405-8. PubMed ID: 21593873
    [No Abstract]   [Full Text] [Related]  

  • 37. The synthetic biology future.
    Sleator RD
    Bioengineered; 2014; 5(2):69-72. PubMed ID: 24561910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent patent applications in microRNAs.
    Nat Biotechnol; 2006 Jan; 24(1):44. PubMed ID: 16404392
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthetic biology: promises and challenges.
    Serrano L
    Mol Syst Biol; 2007; 3():158. PubMed ID: 18091727
    [No Abstract]   [Full Text] [Related]  

  • 40. Biotech-biotech company mergers puzzle investors.
    Dorey E
    Nat Biotechnol; 1998 Jul; 16(7):616. PubMed ID: 9661187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.